Cargando…
Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al.
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993512/ https://www.ncbi.nlm.nih.gov/pubmed/32005276 http://dx.doi.org/10.1186/s13075-020-2106-5 |
_version_ | 1783493051436498944 |
---|---|
author | Masi, Alfonse T. Fleischmann, Roy |
author_facet | Masi, Alfonse T. Fleischmann, Roy |
author_sort | Masi, Alfonse T. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6993512 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-69935122020-02-04 Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al. Masi, Alfonse T. Fleischmann, Roy Arthritis Res Ther Letter BioMed Central 2020-01-31 2020 /pmc/articles/PMC6993512/ /pubmed/32005276 http://dx.doi.org/10.1186/s13075-020-2106-5 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Letter Masi, Alfonse T. Fleischmann, Roy Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al. |
title | Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al. |
title_full | Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al. |
title_fullStr | Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al. |
title_full_unstemmed | Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al. |
title_short | Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al. |
title_sort | does acpa-negative ra consist of subgroups related to sustained dmard-free remission and serological markers at disease presentation? comment on article by boeters dm et al. |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993512/ https://www.ncbi.nlm.nih.gov/pubmed/32005276 http://dx.doi.org/10.1186/s13075-020-2106-5 |
work_keys_str_mv | AT masialfonset doesacpanegativeraconsistofsubgroupsrelatedtosustaineddmardfreeremissionandserologicalmarkersatdiseasepresentationcommentonarticlebyboetersdmetal AT fleischmannroy doesacpanegativeraconsistofsubgroupsrelatedtosustaineddmardfreeremissionandserologicalmarkersatdiseasepresentationcommentonarticlebyboetersdmetal |